Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

BCL2 D103Y

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

BCL2 overexpression (17)

BCL2 expression (9)

BCL2 expression + MYC expression (8)

BCL2 positive (7)

MYC overexpression + BCL2 overexpression (7)

BCL2 overexpression + MCL1 overexpression (2)

BCL2 underexpression (2)

MYC expression + BCL2 expression (2)

BCL2 overexpression + CCND1 overexpression (1)

BCL2 overexpression + MCL1 expression (1)

BCL2 overexpression + MCL1 underxpression + BCL2L1 underexpression (1)

BCL2 overexpression + MYC overexpression (1)

BCL2 positive + LGALS3 expression (1)

BTK expression + BCL2 expression (1)

BTK expression + BCL2 expression + MYC expression (1)

CASP3 overexpression + BCL2 negative (1)

CASP3 underexpression + BCL2 positive (1)

CD20 expression + PAX5 expression + BCL2 expression (1)

CD22 underexpression + BCL2 overexpression (1)

MYC expression + BCL2 expression + BCL6 expression (1)

MYC positive + BCL2 positive (1)

MYC positive + BCL2 positive + BCL6 positive (1)

BCL2 positive + IGH positive (0)

BCL2 overexpression (17)

BCL2 expression (9)

BCL2 expression + MYC expression (8)

BCL2 positive (7)

MYC overexpression + BCL2 overexpression (7)

BCL2 overexpression + MCL1 overexpression (2)

BCL2 underexpression (2)

MYC expression + BCL2 expression (2)

BCL2 overexpression + CCND1 overexpression (1)

BCL2 overexpression + MCL1 expression (1)

BCL2 overexpression + MCL1 underxpression + BCL2L1 underexpression (1)

BCL2 overexpression + MYC overexpression (1)

BCL2 positive + LGALS3 expression (1)

BTK expression + BCL2 expression (1)

BTK expression + BCL2 expression + MYC expression (1)

CASP3 overexpression + BCL2 negative (1)

CASP3 underexpression + BCL2 positive (1)

CD20 expression + PAX5 expression + BCL2 expression (1)

CD22 underexpression + BCL2 overexpression (1)

MYC expression + BCL2 expression + BCL6 expression (1)

MYC positive + BCL2 positive (1)

MYC positive + BCL2 positive + BCL6 positive (1)

BCL2 positive + IGH positive (0)

›

BCL2 D103Y	Chronic Lymphocytic Leukemia	BCL2 D103Y	Chronic Lymphocytic Leukemia	venetoclax + obinutuzumab Resistant: C3 – Early Trials venetoclax + obinutuzumab Resistant : C3	venetoclax + obinutuzumab Resistant: C3 – Early Trials venetoclax + obinutuzumab Resistant : C3
BCL2 D103Y	Chronic Lymphocytic Leukemia	BCL2 D103Y	Chronic Lymphocytic Leukemia	venetoclax + rituximab Resistant: C3 – Early Trials venetoclax + rituximab Resistant : C3	venetoclax + rituximab Resistant: C3 – Early Trials venetoclax + rituximab Resistant : C3